CH631625A5 - Process for the production of a stable insulin preparation having a lasting action - Google Patents
Process for the production of a stable insulin preparation having a lasting action Download PDFInfo
- Publication number
- CH631625A5 CH631625A5 CH47076A CH47076A CH631625A5 CH 631625 A5 CH631625 A5 CH 631625A5 CH 47076 A CH47076 A CH 47076A CH 47076 A CH47076 A CH 47076A CH 631625 A5 CH631625 A5 CH 631625A5
- Authority
- CH
- Switzerland
- Prior art keywords
- insulin
- protein
- solution
- preparation
- dissociating
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/62—Insulins
- C07K14/625—Extraction from natural sources
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biophysics (AREA)
- Endocrinology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Diabetes (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dermatology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DK8375AA DK140801B (da) | 1975-01-15 | 1975-01-15 | Fremgangsmåde til fremstilling af et stabilt langtidsvirkende insulinpræparat. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CH631625A5 true CH631625A5 (en) | 1982-08-31 |
Family
ID=8089535
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CH47076A CH631625A5 (en) | 1975-01-15 | 1976-01-15 | Process for the production of a stable insulin preparation having a lasting action |
Country Status (36)
| Country | Link |
|---|---|
| JP (1) | JPS5946939B2 (nl) |
| AR (1) | AR213088A1 (nl) |
| AT (1) | AT362492B (nl) |
| BE (1) | BE837600A (nl) |
| BR (1) | BR7600206A (nl) |
| CA (1) | CA1094549A (nl) |
| CH (1) | CH631625A5 (nl) |
| CS (1) | CS208147B2 (nl) |
| DD (1) | DD124379A5 (nl) |
| DE (1) | DE2600971C2 (nl) |
| DK (1) | DK140801B (nl) |
| EG (1) | EG11988A (nl) |
| ES (1) | ES444558A1 (nl) |
| FI (1) | FI66751C (nl) |
| FR (1) | FR2297634A1 (nl) |
| GB (1) | GB1524431A (nl) |
| GR (1) | GR58608B (nl) |
| HU (1) | HU175142B (nl) |
| IE (1) | IE42395B1 (nl) |
| IL (1) | IL48845A (nl) |
| IN (1) | IN143279B (nl) |
| IT (1) | IT1054211B (nl) |
| KE (1) | KE2919A (nl) |
| LU (1) | LU74175A1 (nl) |
| MX (1) | MX4052E (nl) |
| MY (1) | MY7900169A (nl) |
| NL (1) | NL166464C (nl) |
| NO (1) | NO146698C (nl) |
| NZ (1) | NZ179733A (nl) |
| OA (1) | OA05209A (nl) |
| PL (1) | PL99927B1 (nl) |
| PT (1) | PT64696B (nl) |
| RO (1) | RO71576A (nl) |
| SE (1) | SE437219B (nl) |
| YU (1) | YU8376A (nl) |
| ZA (1) | ZA7658B (nl) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0278473A1 (en) * | 1987-02-10 | 1988-08-17 | Drug Delivery Systems Inc. | Electrolytic transdermal delivery of proteins |
| EP0278474A1 (en) * | 1987-02-10 | 1988-08-17 | Drug Delivery Systems Inc. | Electrolytic transdermal delivery of polypeptides |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK374579A (da) * | 1979-09-07 | 1981-03-08 | Nordisk Insulinlab | Fremgangsmaade til fremstilling af et injucerbart insulinpraeparat |
| US4459226A (en) * | 1982-02-26 | 1984-07-10 | Eli Lilly And Company | Process for recovering insulin |
| US4801575A (en) * | 1986-07-30 | 1989-01-31 | The Regents Of The University Of California | Chimeric peptides for neuropeptide delivery through the blood-brain barrier |
| US5629020A (en) * | 1994-04-22 | 1997-05-13 | Emisphere Technologies, Inc. | Modified amino acids for drug delivery |
| US5447728A (en) | 1992-06-15 | 1995-09-05 | Emisphere Technologies, Inc. | Desferrioxamine oral delivery system |
| US6221367B1 (en) | 1992-06-15 | 2001-04-24 | Emisphere Technologies, Inc. | Active agent transport systems |
| US5714167A (en) | 1992-06-15 | 1998-02-03 | Emisphere Technologies, Inc. | Active agent transport systems |
| US5643957A (en) | 1993-04-22 | 1997-07-01 | Emisphere Technologies, Inc. | Compounds and compositions for delivering active agents |
| US5750147A (en) | 1995-06-07 | 1998-05-12 | Emisphere Technologies, Inc. | Method of solubilizing and encapsulating itraconazole |
| US6051258A (en) | 1995-06-07 | 2000-04-18 | Emisphere Technologies, Inc. | Proteinoid emulsions and methods for preparation and use thereof |
| EP2077132A1 (en) | 2008-01-02 | 2009-07-08 | Boehringer Ingelheim Pharma GmbH & Co. KG | Dispensing device, storage device and method for dispensing a formulation |
| EP2414560B1 (de) | 2009-03-31 | 2013-10-23 | Boehringer Ingelheim International GmbH | Verfahren zur beschichtung einer oberfläche eines bauteils |
| JP5763053B2 (ja) | 2009-05-18 | 2015-08-12 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | アダプタ、吸入器具及びアトマイザ |
| JP5658268B2 (ja) | 2009-11-25 | 2015-01-21 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | ネブライザ |
| US10016568B2 (en) | 2009-11-25 | 2018-07-10 | Boehringer Ingelheim International Gmbh | Nebulizer |
| WO2011064164A1 (en) | 2009-11-25 | 2011-06-03 | Boehringer Ingelheim International Gmbh | Nebulizer |
| WO2011160932A1 (en) | 2010-06-24 | 2011-12-29 | Boehringer Ingelheim International Gmbh | Nebulizer |
| WO2012130757A1 (de) | 2011-04-01 | 2012-10-04 | Boehringer Ingelheim International Gmbh | Medizinisches gerät mit behälter |
| US9827384B2 (en) | 2011-05-23 | 2017-11-28 | Boehringer Ingelheim International Gmbh | Nebulizer |
| WO2013152894A1 (de) | 2012-04-13 | 2013-10-17 | Boehringer Ingelheim International Gmbh | Zerstäuber mit kodiermitteln |
| JP6643231B2 (ja) | 2013-08-09 | 2020-02-12 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | ネブライザ |
| EP2835146B1 (en) | 2013-08-09 | 2020-09-30 | Boehringer Ingelheim International GmbH | Nebulizer |
| LT3928818T (lt) | 2014-05-07 | 2023-03-27 | Boehringer Ingelheim International Gmbh | Purkštuvas ir talpa |
| JP6580070B2 (ja) | 2014-05-07 | 2019-09-25 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | 容器、ネブライザ、及び使用 |
| PL3139984T3 (pl) | 2014-05-07 | 2021-11-08 | Boehringer Ingelheim International Gmbh | Nebulizator |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1285023A (en) * | 1968-08-09 | 1972-08-09 | Novo Terapeutisk Labor As | Improvements in or relating to injectable insulin preparations |
| US3758683A (en) * | 1971-04-30 | 1973-09-11 | R Jackson | Insulin product |
-
1975
- 1975-01-15 DK DK8375AA patent/DK140801B/da not_active IP Right Cessation
-
1976
- 1976-01-06 ZA ZA00760058A patent/ZA7658B/xx unknown
- 1976-01-07 GR GR49734A patent/GR58608B/el unknown
- 1976-01-07 IN IN41/CAL/76A patent/IN143279B/en unknown
- 1976-01-12 FI FI760058A patent/FI66751C/fi not_active IP Right Cessation
- 1976-01-12 CA CA243,587A patent/CA1094549A/en not_active Expired
- 1976-01-12 NZ NZ179733A patent/NZ179733A/xx unknown
- 1976-01-13 DE DE2600971A patent/DE2600971C2/de not_active Expired
- 1976-01-13 IE IE62/76A patent/IE42395B1/en unknown
- 1976-01-13 SE SE7600284A patent/SE437219B/xx not_active IP Right Cessation
- 1976-01-13 LU LU74175A patent/LU74175A1/xx unknown
- 1976-01-13 IT IT19221/76A patent/IT1054211B/it active
- 1976-01-14 DD DD190805A patent/DD124379A5/xx unknown
- 1976-01-14 BR BR7600206A patent/BR7600206A/pt unknown
- 1976-01-14 NO NO760118A patent/NO146698C/no unknown
- 1976-01-14 PL PL1976186526A patent/PL99927B1/pl unknown
- 1976-01-14 MX MX764822U patent/MX4052E/es unknown
- 1976-01-14 GB GB1309/76A patent/GB1524431A/en not_active Expired
- 1976-01-14 PT PT64696A patent/PT64696B/pt unknown
- 1976-01-14 AT AT21376A patent/AT362492B/de not_active IP Right Cessation
- 1976-01-14 YU YU00083/76A patent/YU8376A/xx unknown
- 1976-01-14 NL NL7600338.A patent/NL166464C/nl not_active IP Right Cessation
- 1976-01-14 RO RO7684491A patent/RO71576A/ro unknown
- 1976-01-14 FR FR7600854A patent/FR2297634A1/fr active Granted
- 1976-01-14 OA OA55703A patent/OA05209A/xx unknown
- 1976-01-15 CS CS76270A patent/CS208147B2/cs unknown
- 1976-01-15 CH CH47076A patent/CH631625A5/de not_active IP Right Cessation
- 1976-01-15 BE BE163542A patent/BE837600A/xx not_active IP Right Cessation
- 1976-01-15 IL IL48845A patent/IL48845A/xx unknown
- 1976-01-15 HU HU76NO198A patent/HU175142B/hu unknown
- 1976-01-15 ES ES444558A patent/ES444558A1/es not_active Expired
- 1976-01-16 JP JP51003293A patent/JPS5946939B2/ja not_active Expired
- 1976-01-17 EG EG16/76A patent/EG11988A/xx active
-
1978
- 1978-01-14 AR AR261924A patent/AR213088A1/es active
-
1979
- 1979-02-07 KE KE2919A patent/KE2919A/xx unknown
- 1979-12-30 MY MY169/79A patent/MY7900169A/xx unknown
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0278473A1 (en) * | 1987-02-10 | 1988-08-17 | Drug Delivery Systems Inc. | Electrolytic transdermal delivery of proteins |
| EP0278474A1 (en) * | 1987-02-10 | 1988-08-17 | Drug Delivery Systems Inc. | Electrolytic transdermal delivery of polypeptides |
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CH631625A5 (en) | Process for the production of a stable insulin preparation having a lasting action | |
| DE69816409T2 (de) | Kristallines Parathyroidhormon | |
| EP0021152B1 (de) | Verfahren zur immunologischen Bestimmung von Basalmembranmaterial, hierfür geeignete Basalmembranfragmente und Verfahren zu deren Herstellung, bzw. Gewinnung | |
| DE69428860T2 (de) | Insulin Formulierung | |
| DE3520228C2 (de) | Wasserlösliche bioaktive Trockenfeststoffzusammensetzung, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Präparate | |
| DE2805663C3 (nl) | ||
| DE69017050T2 (de) | Verfahren zur isolierung von faktor viii. | |
| AT406866B (de) | Hochmolekulare und niedermolekulare fraktionen des von willebrand-faktors | |
| DD244345A5 (de) | Neue peptide | |
| DE1927209A1 (de) | Acyl-substituierte Insuline und Verfahren zu ihrer Herstellung | |
| DD296933A5 (de) | Peptide | |
| DE69712124T2 (de) | Hormones de croissance humaines mutantes et leur utilisation | |
| DE2219635A1 (de) | Insulinprodukt | |
| EP0046979A1 (de) | Analoga des Insulins | |
| DE69133399T2 (de) | Methode zur Herstellung von im Wesentlichen monomeren normalen menschlichen Serum-Albumin | |
| DE1940130C2 (de) | Verfahren zur Reinigung von Insulin, nach diesem Verfahren gereinigtes Insulin und dessen Verwendung | |
| DE2364883C2 (de) | Des-Lys↑2↑↑9↑-Ala↑3↑↑0↑-Schweine- und -Rinderinsulin, Verfahren zu deren Herstellung und diese Insuline enthaltende injizierbare Präparate | |
| DE60318749T2 (de) | Paralytisches peptid von der spitzmaus sowie dessen nutzung in der therapie von neuromuskulären krankheiten | |
| EP0110294A2 (de) | Mittel zur Behandlung der Osteoporose | |
| DE68903670T2 (de) | Physiologisch aktive, fluessige, allergenische zusammensetzungen aus biologischen rohmaterialien. | |
| DE68912250T2 (de) | Mittel zur Prüfung der Adrenokorkikotrophormone-Sekretion. | |
| CH640244A5 (en) | Biologically active substance | |
| DE3877015T2 (de) | Antikoerper enthaltende stabilisierte waesserige zusammensetzung. | |
| US3755569A (en) | Acyl substituted insulins | |
| DE2815758C3 (de) | Peptidkomplexe aus DNS-haltigen Organismen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PL | Patent ceased |